Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Nov 09, 2023 $36.68 $36.68 $34.47 $34.95 522 406
Nov 08, 2023 $38.05 $38.74 $35.60 $36.27 1 720 851
Nov 07, 2023 $37.77 $38.45 $37.02 $38.08 746 188
Nov 06, 2023 $38.79 $39.53 $37.58 $37.79 632 982
Nov 03, 2023 $36.79 $39.99 $36.79 $38.83 1 245 798
Nov 02, 2023 $36.69 $37.44 $36.28 $36.60 985 181
Nov 01, 2023 $35.40 $36.12 $35.05 $36.04 789 606
Oct 31, 2023 $32.86 $35.49 $32.83 $35.40 1 040 627
Oct 30, 2023 $32.77 $33.82 $32.77 $33.08 713 881
Oct 27, 2023 $34.74 $34.74 $32.55 $32.81 1 186 086
Oct 26, 2023 $32.94 $34.76 $32.78 $34.51 1 290 781
Oct 25, 2023 $32.00 $33.45 $31.62 $32.83 1 303 224
Oct 24, 2023 $31.74 $32.88 $31.52 $32.18 1 135 928
Oct 23, 2023 $32.74 $33.26 $31.82 $32.00 851 414
Oct 20, 2023 $33.00 $34.23 $32.45 $33.12 2 054 192
Oct 19, 2023 $32.94 $34.74 $32.33 $33.45 4 052 202
Oct 18, 2023 $34.91 $34.91 $31.62 $31.73 2 619 827
Oct 17, 2023 $37.25 $38.92 $36.79 $36.83 1 314 747
Oct 16, 2023 $34.30 $39.44 $33.67 $37.02 3 178 330
Oct 13, 2023 $32.29 $33.62 $32.01 $33.57 765 069
Oct 12, 2023 $36.14 $36.14 $32.36 $32.64 874 279
Oct 11, 2023 $36.67 $37.07 $35.69 $36.26 407 744
Oct 10, 2023 $35.69 $36.84 $35.59 $36.60 805 541
Oct 09, 2023 $34.89 $35.69 $34.41 $35.68 1 161 048
Oct 06, 2023 $34.50 $35.82 $34.50 $35.23 1 020 164
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT